Skip to main content

Table 1 Patient characteristics (n = 30)

From: Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study

Characteristic

No. (%)

Age

Median (IQR)

 

55.5 (51–65.5)

Gender

 Male

14 (47)

 Female

16 (53)

ECOG Performance Status

 ECOG PS 0

21 (70)

 ECOG PS 1

9 (30)

Tumor localization

 Extrahepatic

6 (20)

 Intrahepatic

17 (57)

 Gallbladder

5 (17)

 Ampulla vateri

2 (7)

Stage TNM

 T1/T2/T3/T4

4 (13)/15 (50)/11 (37)/0 (0)

 N0/1

20 (67)/10 (33)

Margin Status

 R0

28 (93)

 R1

2 (7)

Operative Procedurea

 Major hepatectomy

17 (57)

 Hepatopancreaticoduodenectomy

1 (3)

 Gall bladder bed resection

9 (30)

 Pancreaticoduodenectomy

5 (17)

Time of initiation of Chemotherapy (days)

Median (IQR) 49.5 (39.8–64.5)

  1. Abbreviations: IQR Interquartile Range, ECOG Eastern Cooperative Oncology Group, TNM tumor node metastasis, R residual tumor after treatment
  2. aIncludes multiple counts